Responses
Clinical/translational cancer immunotherapy
Original research
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
Compose a Response to This Article
Other responses
No responses have been published for this article.
